Our study significantly expands the knowledge regarding FLT3 expression in ALL as well as AML by demonstrating amplified expression levels in infants, children, and adults with KMT2A/MLL-R+ B-ALL and children with KMT2A/MLL-R+ AML. Here, FLT3 is linked to acute myeloid leukemia.